Accounts Receivable, after Allowance for Credit Loss, Current in USD of TG THERAPEUTICS, INC. from Q4 2022 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Tg Therapeutics, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2022 to Q3 2025.
- Tg Therapeutics, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $265M, a 129% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)